A previous study reported that glioma cells with IDH1 mutation produce 2-hydroxyglutarate, which promotes HIF-1α degradation, accompanied by the downregulation of glycolysis-related genes including SLC2A1, PDK1, LDHA, and SLC16A3 [39]. The gene discussed is SLC2A1; the disease is central nervous system cancer.